These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6405004)

  • 1. [Long-term antithrombotic treatment in coronary disease].
    Hodara M; Samama M
    J Mal Vasc; 1983; 8(1):28-32. PubMed ID: 6405004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on secondary prevention of myocardial infarct (EPSIM). Work of the EPSIM research group].
    Arch Mal Coeur Vaiss; 1982 Dec; 75 Spec No():1-130. PubMed ID: 6820624
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical pharmacology of drugs used in thromboembolism].
    Orzechowska-Juzwenko K
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1663-7. PubMed ID: 6679090
    [No Abstract]   [Full Text] [Related]  

  • 4. [Platelet suppressant therapy and oral anticoagulants in the secondary prevention of acute myocardial infarction (authors transl)].
    Theiss W; Blömer H
    Herz; 1979 Oct; 4(5):419-27. PubMed ID: 391686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
    Klimt CR; Doub PH; Doub NH
    Thromb Haemost; 1976 Feb; 35(1):49-56. PubMed ID: 785688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
    Rühle H
    Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541
    [No Abstract]   [Full Text] [Related]  

  • 7. A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
    Gianetti J; Gensini G; De Caterina R
    Thromb Haemost; 1998 Dec; 80(6):887-93. PubMed ID: 9869155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
    Bousser MG
    J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulation in cardiology].
    Meier B
    Ann Cardiol Angeiol (Paris); 1995 Dec; 44(10):567-77. PubMed ID: 8787333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
    Reikvam A; Madsen S; Landmark K
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral arterial revascularization: which antithrombotic agents?].
    Haulon S; Susen S; Koussa M; Jude B
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1278-84. PubMed ID: 11794970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
    Verstraete M
    Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244
    [No Abstract]   [Full Text] [Related]  

  • 15. [The current aspects of antithrombotic therapy].
    Bŭcharova V
    Vutr Boles; 1990; 29(3):14-20. PubMed ID: 2178290
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anticoagulants and thrombocyte aggregation inhibitors in the treatment of heart infarct. A survey].
    Spitzer W; Durst OE; Lang E
    Fortschr Med; 1983 Jan; 101(1-2):22-30. PubMed ID: 6826125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications and limitations of anticoagulant treatment in elderly patients].
    Emeriau JP; Decamps A; Dulhoste MN; Labbé T; Bourdel-Marchasson I; Bonnel C; Manciet G
    Rev Prat; 1990 May; 40(15):1375-8. PubMed ID: 2356427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulants in coronary disease].
    Popescu P
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(5):329-34. PubMed ID: 14368
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG
    Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of cardiovascular events after acute coronary syndrome.
    Wallentin L
    Semin Vasc Med; 2005 Aug; 5(3):293-300. PubMed ID: 16123917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.